cerrar
Tagged with USA

Bill Sibold Swaps Sanofi for Biotech Seeking First NASH FDA…
After a 12-year stint at Sanofi, Bill Sibold is leaving Big Pharma to join the Pennsylvania-based biotech Madrigal Pharmaceuticals as CEO. Sibold, no…

Vivek Ramaswamy: The Biotech Firebrand Bidding to be President
Having become one of the 20 youngest US billionaires as founder and CEO of disruptive biotech firm Roivant Sciences, Vivek Ramaswamy has now set his…

First Ten Drugs Subject to Medicare Pricing Negotiations
The subject of intense industry criticism from the likes of lobby groups, Big Pharma, and biotech alike, the Inflation Reduction Act (IRA) subjects…

New Illumina Boss Inherits Long List of Woes
Illumina’s newly appointed CEO, Jacob Thaysen, will take the reins of the gene sequencing giant at the end of September. Falling heir to the…

JLABS’ Global Head On Open Innovation & Writing…
Biotech and life sciences companies have a habit of clustering together, creating shared ecosystems to drive innovation. For going on 12 years Johnson…

What’s on the Mind of Amgen Execs?
Amgen has forged a solid position as one of the world’s largest independent biotechnology companies. With a market capitalisation of some USD 130…

Office-Lab Conversions: A Golden Goose Laying Golden Eggs?
With office occupation rates on the slide and the life sciences industry's demand for lab space on the rise, the repurposing of existing offices into…

Cell & Gene Therapy Approvals & Sector Snapshot 2023
The Alliance for Regenerative Medicine (ARM) brands itself as the leading international advocacy organization championing the benefits of engineered…

Pfizer, Roche, Daiichi Bosses to Head IFPMA’s New CEO…
Following the appointment of new boards at the US innovative pharma industry body PhRMA, and its European counterpart EFPIA, it is global group the…

Four Insights from Amgen CEO Bob Bradway
Founded in 1980 “at the dawn of a biotechnology revolution,” Amgen has held its ground throughout its more than 40-year history with innovative…

Potential Impacts of the US Antitrust Environment on…
David H. Crean, Ph.D., Managing Partner at Cardiff Advisory, provides his insights on the potential impact of the US Federal Trade Commission…

RAFARM’s Stateside Strategy
One of Greece’s leading domestic pharmaceutical companies, RAFARM has had a stellar recent history, including a momentous entry into the US market.…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here